Trial Profile
Dabigatran Treatment Following Transient Ischemic Attack and Minor Stroke
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 30 Nov 2017
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary)
- Indications Embolism and thrombosis; Stroke; Transient ischaemic attacks
- Focus Therapeutic Use
- Acronyms DATAS
- 29 Jan 2013 New trial record